National Cancer Institute researchers have teamed up with AxCell Biosciences to study how two families of proteins participate in signal transduction pathways, AxCell said Oct. 10.
The collaboration, which is still in preliminary stages, will employ AxCell’s technology for studying interactions between certain proteins and peptide sequences, and investigate the roles of two protein families, the serine-threonine and tyrosine kinases, in signal transduction.